Rtw Investments »

Mind Medicine Mindmed shares owned by Rtw Investments

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.0M 300k 13.39

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Mind Medicine Mindmed

BlackRock
venBio Select Advisor
Driehaus Capital Management
Blackstone Group
Vanguard Group
State Street Corporation
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Deep Track Capital
OrbiMed Advisors
Susquehanna International
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Mind Medicine Mindmed